Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs202128397
rs202128397
0.710 GeneticVariation BEFREE We report the long-term clinicopathologic observation of a Japanese female patient with SRNS caused by a newly identified compound heterozygous mutation of CRB2 (p.Arg628Cys and p.Gly839Trp located in the 10th and 11th epidermal growth factor-like domains, respectively). 29473663

2018

dbSNP: rs202128397
rs202128397
T 0.710 GeneticVariation CLINVAR

dbSNP: rs587776576
rs587776576
WT1
T 0.700 CausalMutation CLINVAR Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. 1302008

1992

dbSNP: rs119473033
rs119473033
T 0.700 CausalMutation CLINVAR

dbSNP: rs121907900
rs121907900
WT1
A 0.700 GeneticVariation CLINVAR

dbSNP: rs386833945
rs386833945
A 0.700 GeneticVariation CLINVAR

dbSNP: rs748106387
rs748106387
A 0.700 CausalMutation CLINVAR

dbSNP: rs879255251
rs879255251
TGGCGCGGCCCCGGCCC 0.700 GeneticVariation CLINVAR

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE NPHS2 gene analysis showed R229Q polymorphism in six SRNS (30%), four SSNS (4.4%) and 13 controls (26%). 24519673

2014

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis. 24715228

2014

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE The pathogenicity of the NPHS2 homozygous p.R229Q variant in steroid-resistant nephrotic syndrome (SRNS) is doubtful. 23800802

2013

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE In this preliminary study, we showed that NPHS2 gene p.R229Q polymorphism does not present in Iranian-Azeri population with SRNS. 24072153

2013

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. 22578956

2012

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE Six additional cases with late childhood- and adult-onset SRNS were compound heterozygotes for p.R229Q and one pathogenic mutation, mostly p.A284V. p.R229Q was more frequent among SRNS cases relative to controls (odds ratio=2.65; P=0.02). 20947785

2011

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE In steroid-resistant nephrotic syndrome (SRNS) Machuca et al. report that mutations of the recessive podocin gene cause adult-onset SRNS if the R229Q genetic variant occurs in a compound heterozygous state with another podocin mutation. 19282856

2009

dbSNP: rs61747728
rs61747728
0.080 GeneticVariation BEFREE Our study shows that compound heterozygosity for p.R229Q is associated with adult-onset steroid-resistant NS, mostly among patients of European and South American origin. 19145239

2009

dbSNP: rs760415536
rs760415536
0.010 GeneticVariation BEFREE However, four novel polymorphisms including - 257 T > C, - 266 G > A, - 293 G > C, and - 21 G > A found in the promoter region of TRPC6 gene that may be involved in SRNS in our cohort. 31529341

2019

dbSNP: rs1071630
rs1071630
0.010 GeneticVariation BEFREE The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10<sup>-11</sup>; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10<sup>-13</sup>; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). 29277510

2018

dbSNP: rs1129740
rs1129740
0.010 GeneticVariation BEFREE The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10<sup>-11</sup>; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10<sup>-13</sup>; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). 29277510

2018

dbSNP: rs1136759
rs1136759
0.010 GeneticVariation BEFREE The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10<sup>-11</sup>; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10<sup>-13</sup>; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). 29277510

2018

dbSNP: rs17878703
rs17878703
0.010 GeneticVariation BEFREE The 2 HLA-DQA1 variants were significantly associated with SSNS in African American children (C34Y: P=5.7 × 10<sup>-11</sup>; OR, 3.53; 95% CI, 2.33-5.42; F41S: P=1.2 × 10<sup>-13</sup>; OR, 4.08; 95% CI, 2.70-6.28), but not with SRNS (C34Y: P=0.6; F41S: P=0.2). 29277510

2018

dbSNP: rs200482683
rs200482683
0.010 GeneticVariation BEFREE We propose that not only the p.R229Q variant, but also the p.V290M mutation should be screened in Central and Eastern European patients with late-onset SRNS. 23242530

2013

dbSNP: rs753350907
rs753350907
0.010 GeneticVariation BEFREE The pathogenicity of the NPHS2 homozygous p.R229Q variant in steroid-resistant nephrotic syndrome (SRNS) is doubtful. 23800802

2013

dbSNP: rs1001703993
rs1001703993
0.010 GeneticVariation BEFREE In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. 22578956

2012

dbSNP: rs74315344
rs74315344
0.010 GeneticVariation BEFREE In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. 22578956

2012